l carnitine diabetes mellitus dysregulation in diabetic kidney disease: from pathogenic mechanism to precision biomarker | Journal of Translational Medicine L-Carnitine in the treatment of
Description
This disease responds to oral carnitine that, in pharmacological doses, enters cells using the amino acid transporter B 0,+
Third, we used mean and SDs for pooling VAS
Lpez-GamberoAJSanjuanCSerrano-CastroPJSurezJDe FonsecaFR
Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics
